Loading ...

Carol Soppe

Immune Tolerance Network

Associate Director, Clinical Operations Clinical Trials Group

http://www.immunetolerance.org

Assessment Group

csoppe@immunetolerance.org

Work:

415-353-4879

Mobile:

415-278-1706

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN028AI

-

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

ITN041AI

-

A Research Trial of Aralast in New Onset Diabetes

ITN045AI

-

Inducing Remission in Type 1 Diabetes With Alefacept

ITN058AI

-

Tocilizumab (TCZ) in New-onset Type 1 Diabetes

ITN065AI

-

TCZ in Pediatric New-onset T1D

ITN066AI

-

Type 1 Diabetes Extension Study

ITN078AI

-

Immunotherapy to Preserve Residual Insulin in New-onset Type One Diabetes

ITN819AI

-

Type 1 Diabetes Immunotherapy Using Polyclonal Tregs

Bio:

Admin Links

Shortcuts

ITN Documents

Links